key: cord-0778142-cljg2nml
authors: Troeltzsch, Matthias; Gogl, Markus; Berndt, Ronald; Troeltzsch, Markus
title: Oral lichen planus following the administration of vector‐based COVID‐19 vaccine (Ad26.COV2.S)
date: 2021-09-30
journal: Oral Dis
DOI: 10.1111/odi.14025
sha: 9b2b3fd6d9ae8edaab487e85c349befb25922344
doc_id: 778142
cord_uid: cljg2nml

nan

Pfizer), and inactivated SARS-CoV-2 virus (Sinopharm). The safety and efficacy profiles of all vaccines appear to be favorable (Wu et al., 2021) . Limited local reactions at the injection site are most commonly reported after the vaccine administration (Wu et al., 2021) . Severe adverse events seem to be rare (0.1%) (Wu et al., 2021) .

In the progress of the vaccination campaign, more knowledge about possible side effects is surfacing. It is difficult to establish causative associations between conspicuous (possibly rare) clinical findings and COVID vaccine administration (Anaya-Saavedra, 2021). However, a meticulous surveillance of possible side effects is warranted.

Cutaneous/mucosal side effects (allergic and non-allergic) in the wake of vaccinations are well described (Rosenblatt & Stein, 2015) . A rare vaccination-associated event is the onset of lichen planus (LP) (Lai & Yew, 2017) . A review published in 2017 found a total of 33 cases of LP arising after various vaccinations (Lai & Yew, 2017) . Most cases of LP (very rarely with oral manifestations) were observed within a fortnight following a Hepatitis B, Influenza, or Herpes zoster vaccination (inactivated/attenuated virus vaccinations) (Lai & Yew, 2017) .

Recently published reports have associated COVID-19 vaccinations with the emergence of LP or the exacerbation of oral LP (OLP) (Hiltun et al., 2021; Kulkarni & Sollecito, 2021; Merhy et al., 2021) .

LP and OLP are the clinical correlate of an autoimmunologic reaction of mainly CD8+ cytotoxic T cells against epidermal basal layer keratinocytes which induces keratinocyte apoptosis (Nogueira et al., 2015) . This process is maintained by the release of IL-2, TNFα, and IFNγ by CD4+ (Th1) lymphocytes (Hiltun et al., 2021; Nogueira et al., 2015) . The LP/OLP-associated immune reaction is represented histologically by the accumulation of lymphocytic infiltrates in the basal epidermal layer.

An intended effect of all COVID-19 vaccines is the broad immune system stimulation which induces a T-cell driven response with B-cell activation, antibody production, and increased levels of cytokines including IL-2, TNFα, and IFNγ (Alter et al., 2021) .

Long-lasting immunologic responses have been shown for the Ad26. 

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Oral manifestations accompanying and related to COVID-19: Overlooking the obvious

COVID-19: A possible trigger for oral lichen planus?

Lichen planus arising after COVID-19 vaccination

COVID-19 vaccination: Possible short-term exacerbations of oral mucosal diseases

Lichen planus and lichenoid drug eruption after vaccination

New-onset cutaneous lichen planus triggered by COVID-19 vaccination

Oral lichen planus: an update on its pathogenesis

Cutaneous reactions to vaccinations

Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment

Evaluation of the safety profile of COVID-19 vaccines: A rapid review